NICE To Be Sidelined In Assessing Medicine Cost Effectiveness

BMI View: The adoption of value-based pricing in place of the National Institute for Health and Clinical Excellence (NICE)'s cost-effectiveness calculations will improve the chances of innovative medicines entering the NHS. However, we believe that providing a satisfactory definition of the word 'value' will be difficult. In the past, the NICE has come under attack for its definition of

To read the full article, please choose one of the following options: